73 Results

People

  1. Motzer
    Motzer
  2. D'Angelo
    D'Angelo
  3. Voss
    Voss
  4. Carlo
    Carlo
  5. Chen
    Chen
  6. Gupta
    Gupta
  7. Kotecha
    Kotecha
  8. Lacouture
    Lacouture
  9. Shah
    Shah
  10. Adusumilli
    Adusumilli

Groups

  1. Department of Medicine (60)
  2. Solid Tumor Oncology Division (48)
  3. Genitourinary Oncology Service (25)
  4. Hematologic Malignancies, Division of (19)
  5. Division of Subspecialty Medicine (11)
  6. Sarcoma Service (9)
  7. Weinberg Fellows (9)
  8. Graduate Medical Education (8)
  9. GME, Medicine (7)
  10. Sloan Kettering Institute Postdocs (7)
  1. "avelumab"
Formats
  1. Journal Article (38)
  2. Review (23)
  3. Research Letter (5)
  4. Guidelines (3)
  5. Editorial (2)
  6. Book Section (1)
  7. Correspondence (1)
Groups
  1. Department of Medicine (60)
  2. Solid Tumor Oncology Division (48)
  3. Genitourinary Oncology Service (25)
  4. Hematologic Malignancies, Division of (19)
  5. Division of Subspecialty Medicine (11)
  6. Sarcoma Service (9)

More Groups

People
  1. Robert Motzer (15)
  2. Sandra D'Angelo (9)
  3. Martin Voss (5)
  4. Mario Lacouture (4)
  5. Neil Shah (4)
  6. Carol Chen (3)

More People

Years
  1. 2025 (6)
  2. 2024 (16)
  3. 2023 (13)
  4. 2022 (2)
  5. 2021 (11)
  6. 2020 (13)

More Years

Publications
  1. ESMO Open (5)
  2. European Urology (5)
  3. Annals of Oncology (3)
  4. Journal for ImmunoTherapy of Cancer (3)
  5. Journal of the American Academy of Dermatology (3)
  6. Frontiers in Immunology (2)

More Publications

Publishers
  1. Elsevier Science, Inc. (9)
  2. Elsevier Inc. (8)
  3. European Society for Medical Oncology (5)
  4. Wiley Blackwell (5)
  5. Frontiers Media S.A. (4)
  6. Oxford University Press (4)

More Publishers

Results (73)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Avelumab + axitinib versus sunitinib as first-line treatment for patients with advanced renal cell carcinoma: Final analysis of the phase III JAVELIN Renal 101 trial
    Journal Article

    Choueiri, T. K.; Penkov, K.; Uemura, H.; Campbell, M. T.; Pal, S.; Kollmannsberger, C.; Lee, J. L.; Venugopal, B.; van den Eertwegh, A. J. M.; Negrier, S.; more...
    Annals of Oncology (2025)

    Fulltext@MSK | Save
  • Off-label use of first-line immunotherapy for metastatic renal cell carcinoma
    Journal Article

    McManus, H. D.; Long, J. B.; Westvold, S. J.; Leapman, M. S.; Hurwitz, M. E.; Mitchell, A. P.; Pollack, C. E.; Gross, C. P.; Dinan, M. A.
    Clinical Genitourinary Cancer (2025)

    Fulltext@MSK | Save
  • Gene expression of prostate-specific membrane antigen (FOLH1) in clear cell renal cell carcinoma predicts angiogenesis and response to tyrosine kinase inhibitors
    Journal Article

    Khaleel, S.; Perera, M.; Papa, N.; Kuo, F.; Golkaram, M.; Rappold, P.; Kotecha, R. R.; Coleman, J.; Russo, P.; Motzer, R.; more...
    Urologic Oncology: Seminars and Original Investigations (2025)

    Fulltext@MSK | Save
  • Neoadjuvant chemotherapy for newly diagnosed, advanced ovarian cancer: ASCO guideline update
    Guidelines

    Gaillard, S.; Lacchetti, C.; Armstrong, D. K.; Cliby, W. A.; Edelson, M. I.; Garcia, A. A.; Ghebre, R. G.; Gressel, G. M.; Lesnock, J. L.; Meyer, L. A.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • First and second-line treatments in metastatic renal cell carcinoma
    Review

    Barragan-Carrillo, R.; Saad, E.; Saliby, R. M.; Sun, M.; Albiges, L.; Bex, A.; Heng, D.; Mejean, A.; Motzer, R. J.; Plimack, E. R.; more...
    European Urology (2025)

    Fulltext@MSK | Save
  • Intensification approaches and treatment sequencing in metastatic castration-resistant prostate cancer: A systematic review
    Review

    Francini, E.; Agarwal, N.; Castro, E.; Cheng, H. H.; Chi, K. N.; Clarke, N.; Mateo, J.; Rathkopf, D.; Saad, F.; Tombal, B.
    European Urology (2025)

    Fulltext@MSK | Save
  • Reevaluating the role of platinum-based chemotherapy in the evolving treatment landscape for patients with advanced urothelial carcinoma
    Review

    Zhang, T.; Tan, A.; Shah, A. Y.; Iyer, G.; Morris, V.; Michaud, S.; Sridhar, S. S.
    The Oncologist (2024)

    Fulltext@MSK | Save
  • Biomarker analyses investigating disease biology and associations with outcomes in the JAVELIN Merkel 200 trial of avelumab in metastatic Merkel cell carcinoma
    Journal Article

    D'Angelo, S. P.; Lebbé, C.; Nghiem, P.; Brohl, A. S.; Mrowiec, T.; Leslie, T.; Georges, S.; Güzel, G.; Shah, P.
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • Optimizing rectal cancer treatment: A path towards personalization
    Editorial

    Romesser, P. B.; Cercek, A.
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • Chimeric antigen receptor T-cells: A review on current status and future directions for relapsed/refractory multiple myeloma
    Review

    Hamadeh, I. S.; Friend, R.; Mailankody, S.; Atrash, S.
    Frontiers in Oncology (2024)

    Fulltext@MSK | Save